Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway
{{output}}
T-lymphocytes have the potential to recognize cancer antigens as foreign and therefore eliminate them. However, immune checkpoints such as cytotoxic T-lymphocyte-associated antigen (CTLA)-4 and programmed cell death (PD)-1 receptor and its ligands (PD-L1, PD-L... ...
